Holen Sie sich die Stockscreener-App
10.19
0.29%
-0.03
Vorhandelsmarkt:
10.38
0.19
+1.86%
Schlusskurs vom Vortag:
$10.22
Offen:
$10.21
24-Stunden-Volumen:
9.05M
Relative Volume:
0.81
Marktkapitalisierung:
$45.61B
Einnahmen:
$14.35B
Nettoeinkommen (Verlust:
$1.85B
KGV:
25.33
EPS:
0.4023
Netto-Cashflow:
-
1W Leistung:
+0.79%
1M Leistung:
-0.88%
6M Leistung:
+2.10%
1J Leistung:
+23.97%
1-Tages-Spanne:
$10.11
$10.30
1-Wochen-Bereich:
$10.09
$10.31
52-Wochen-Spanne:
$8.12
$10.80
Haleon Plc Adr Stock (HLN) Company Profile
Vergleichen Sie HLN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HLN
Haleon Plc Adr
|
10.19 | 45.61B | 14.35B | 1.85B | 0 | 0.4023 |
|
ZTS
Zoetis Inc
|
146.85 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.93 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.31 | 15.25B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.25 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Haleon Plc Adr Stock (HLN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-01-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2024-08-06 | Eingeleitet | Berenberg | Buy |
| 2024-08-06 | Herabstufung | Goldman | Buy → Neutral |
| 2024-06-05 | Eingeleitet | Berenberg | Buy |
| 2024-04-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-11 | Fortgesetzt | Jefferies | Buy |
| 2023-11-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-05-24 | Eingeleitet | Stifel | Hold |
| 2023-04-06 | Hochstufung | Argus | Hold → Buy |
| 2023-04-04 | Eingeleitet | Bernstein | Outperform |
| 2022-12-07 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-09-28 | Eingeleitet | Argus | Hold |
Alle ansehen
Haleon Plc Adr Aktie (HLN) Neueste Nachrichten
Haleon PLC Executes Share Buyback to Optimize Capital Structure - TipRanks
Haleon takes full control of China JV with $0.2 billion deal - Investing.com
Haleon finalizes full ownership of Chinese JV for $0.2 billion - Investing.com
Haleon Announces PDMR Share Transactions in Compliance with UK Regulations - TipRanks
Haleon PLC Executes Share Buyback Program - TipRanks
Haleon receives A3 rating upgrade from Moody’s with stable outlook By Investing.com - Investing.com India
Haleon receives A3 rating upgrade from Moody's with stable outlook - Investing.com
Haleon PLC Executes Share Buyback to Enhance Shareholder Value - TipRanks
Haleon sets date for virtual 2025 Annual General Meeting By Investing.com - Investing.com South Africa
Haleon PLC Executes Share Buyback to Strengthen Market Position - TipRanks
Haleon PLC Announces Virtual 2025 Annual General Meeting - TipRanks
Haleon schedules virtual AGM for late May - Investing.com
Haleon sets date for virtual 2025 Annual General Meeting - Investing.com
Haleon updates share count and voting rights - Investing.com
Haleon plc launches £330 million share buyback By Investing.com - Investing.com South Africa
Haleon plc launches £330 million share buyback - Investing.com India
Haleon executives receive conditional share awards - Investing.com India
Haleon plc releases 2024 annual report and Form 20-F - Investing.com India
Pfizer to Exit Sensodyne-Maker Haleon With Final Stake Sale - MSN
GSK Stock Recovers, Rises Around 17% YTD: Time To Buy, Sell Or Hold? - Barchart
Pfizer Sells Remaining 7.3% Stake In Haleon For Around 3.3B - Barchart
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B - Yahoo Finance
Pfizer Offloads Its Last 7% Stake In Consumer Health Haleon For Over $3 Billion - Benzinga
Haleon completes share buyback with Pfizer exit - Investing.com
Haleon completes share buyback with Pfizer exit By Investing.com - Investing.com South Africa
Haleon plc to buy back shares from Pfizer in £170 million deal By Investing.com - Investing.com South Africa
Pfizer plans to sell final stake in Sensodyne producer HaleonBloomberg - Investing.com India
Haleon plc to buy back shares from Pfizer in £170 million deal - Investing.com India
Haleon to buy back shares from Pfizer in off-market deal By Investing.com - Investing.com South Africa
Haleon to buy back shares from Pfizer in off-market deal - Investing.com India
Pfizer offers for sale entire residual shareholding in Haleon - TipRanks
Haleon reports executive share acquisitions - Investing.com India
Haleon reports executive share acquisitions By Investing.com - Investing.com UK
HSBC cuts Haleon stock rating, maintains GBP4.20 target - Investing.com
Haleon Faces Headwinds From Weak Flu Season but Reaps Benefits From New Innovations - Morningstar
Why Haleon PLC Sponsored ADR Shares Are Under Scrutiny - TipRanks
Haleon PLC Reports Strong 2024 Financial Performance - TipRanks
Haleon PLC Reports 2024 Full-Year Results with Strong Organic Growth - TipRanks
HALEON ADR earnings beat, revenue fell short of estimates By Investing.com - Investing.com UK
Haleon PLC Reports Strong 2024 Financial Results and Strategic Progress - TipRanks
Haleon PLC Announces Shareholder Structure Change with Pfizer’s Conversion - TipRanks
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Haleon announces board change as Pfizer reduces stake - Investing.com
Haleon executives acquire shares under reward plan - Investing.com
Former Haleon Exec Appointed MD Of Kenvue’s Northern Europe Business - KamCity
Haleon plc ADR (HLN) Stock: A Year of Market Fluctuations - The InvestChronicle
Have you been able to find a good deal on Haleon plc ADR’s shares? - US Post News
Finanzdaten der Haleon Plc Adr-Aktie (HLN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.50%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):